Cancer
Malignant Colon Neoplasm
CI-CAN-00007995Explore in graph →
Top-level225 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00007995Explore in graph →
Clinical trials
1,196 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (139)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02466906 | RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer | unknown | Phase 2 | 60 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 20, 2016 | clinicaltrials |
| NCT01675999 | Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer(ECKINOXE) | unknown | Phase 2 | 186 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jan 15, 2016 |
| clinicaltrials |
| NCT01995591 | Indocyanine Green (ICG) in the ex Vivo Detection of Sentinel Lymph Node (SLN)in Colon Cancer(2068) | completed | — | 20 | Jules Bordet InstituteOTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00122135 | A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making(Aim3) | completed | N/A | 120 | VA Office of Research and DevelopmentFED | 1 | Dec 14, 2015 | clinicaltrials |
| NCT02458664 | BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer(BASE HSP110) | unknown | — | 597 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 2, 2015 | clinicaltrials |
| NCT01111838 | Clinical and Translational Study of STA-9090 | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT01186705 | Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer | terminated | Phase 2 | 1 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT02291744 | A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients | unknown | Phase 2 | 130 | Fudan UniversityOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT00402961 | Trial of Acupuncture for Reduction of Post-Colectomy Ileus | completed | Phase 2 | 90 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 12, 2015 | clinicaltrials |
| NCT01703910 | Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic | completed | Phase 2 | 29 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT02226107 | Latino Peers as Patient Navigators for Colon Cancer Screening | completed | N/A | 85 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 1, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01483443 | Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Cancer Patients | completed | Phase 3 | 140 | Gachon University Gil Medical CenterOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT00188305 | A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients | completed | Phase 3 | 252 | University Health Network, TorontoOTHER | 1 | Aug 17, 2015 | clinicaltrials |
| NCT01062919 | Local Anesthetic Wound Infusion and Functional Recovery After Colon Surgery | terminated | N/A | 10 | Franco CarliOTHER | 1 | Aug 4, 2015 | clinicaltrials |
| NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | unknown | Phase 2 / Phase 3 | 360 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 3, 2015 | clinicaltrials |
| NCT02512263 | Assessment of Adherence and Efficiency of a Home-based Training Program on Muscular Strength, Endurance and Qol for Colon Cancer Patients | unknown | N/A | 50 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jul 30, 2015 | clinicaltrials |
| NCT00100841 | Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer | completed | Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jul 27, 2015 | clinicaltrials |
| NCT01482741 | Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging | completed | — | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT02148406 | Programs to Support You During Chemotherapy (Pro-You)(Pro-You) | completed | N/A | 3 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 23, 2015 | clinicaltrials |
| NCT01205022 | Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 3 | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01294826 | Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer | completed | Phase 1 | 20 | Swedish Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01238965 | Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy | terminated | Phase 1 | 7 | University of Southern CaliforniaOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01838109 | Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery | completed | N/A | 174 | Seoul National University HospitalOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01108107 | Neoadjuvant Treatment of Colon Cancer | completed | Phase 2 | 76 | Vejle HospitalOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT01198535 | Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | May 18, 2015 | clinicaltrials |
| NCT02235324 | Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT02079389 | The Value of Laparoscopic Ultrasound in Patients Undergoing Laparoscopic Resection for Cancer of the Colon or Rectum | completed | N/A | 280 | Odense University HospitalOTHER | 1 | May 5, 2015 | clinicaltrials |
| NCT01092078 | Community-based Approaches to Treating Hypertension and Colon Cancer Prevention(MISTER-B) | completed | N/A | 740 | NYU Langone HealthOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT00032110 | Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00077298 | Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00826800 | Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer | terminated | N/A | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01882972 | Strength for Health | withdrawn | N/A | 0 | Loyola UniversityOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00551421 | Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2015 | clinicaltrials |
| NCT01440127 | Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers | terminated | Phase 1 | 9 | Tufts Medical CenterOTHER | 1 | Mar 26, 2015 | clinicaltrials |
| NCT01378013 | SurgicAl Metabolic Phenotyping Longitudinal Evaluation Study(SaMPLE) | completed | — | 50 | Imperial College LondonOTHER | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00753415 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | completed | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2015 | clinicaltrials |
| NCT00103311 | SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Mar 2, 2015 | clinicaltrials |
| NCT00754494 | Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 6, 2015 | clinicaltrials |
| NCT02331641 | Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases. | completed | — | 554 | University of MilanOTHER | 0 | Jan 6, 2015 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00972036 | Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy | completed | Phase 1 | 32 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 11, 2014 | clinicaltrials |
| NCT00975247 | Impact of a Novel Patient Educational Booklet on Colonoscopy Quality | completed | N/A | 500 | VA Greater Los Angeles Healthcare SystemFED | 1 | Dec 10, 2014 | clinicaltrials |
| NCT01003600 | Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information | completed | — | 177 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT02305368 | Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4(Oncogramme) | completed | — | 20 | University Hospital, LimogesOTHER | 0 | Dec 2, 2014 | clinicaltrials |
| NCT00646607 | FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer(TOSCA) | completed | Phase 3 | 3,756 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Nov 26, 2014 | clinicaltrials |
| NCT02288611 | The Impact of Palm Date Intake on Colon Health Biomarkers(AJWA) | completed | N/A | 22 | University of ReadingOTHER | 0 | Nov 11, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Jan 20, 2016source: clinicaltrials